Understanding GLP-1 Compounded vs
A retatrutida no tem registro na Anvisa e no est disponvel para venda nem prescrio fora de estudos clnicos
Patients treated with tesamorelin for 52 weeks (T-T group) showed no change between Weeks 26 and 52 in mean trunk fat (increase of 0.1 kg in Study 1 and decrease of 0.5 kg in Study 2, respectively, compared with an increase of 1.4 kg in patients in the T-P group in Study 1 and an increase of 1.09 kg in Study 2, respectively) nor was there a change from Week 26 baseline in mean lean body mass (decrease of 0.1 kg in Study 1 and increase of 0.1 kg in Study 2, respectively, compared with a decrease of 1.8 kg in patients in the T-P group in Study 1 and a decrease of 1.7 kg in Study 2, respectively)
Eftekhari, S., Montazeri, H., & Tarighi, P
Among the reports with available data, half of the cases were observed in adults (1865 years)